反応 #2375

ord-46a2349036204912b3e748e1dead945d

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    温度is refluxed for 18 hours
  2. 2
    その他the precipitated crystals are removed by filtration
  3. 3
    抽出The filtrate is extracted with ethyl acetate
  4. 4
    洗浄the ethyl acetate layer is washed
  5. 5
    その他dried
  6. 6
    濃縮concentrated to dryness under reduced pressure
  7. 7
    その他The residue is purified by silica gel column chromatography (solvent; n-hexane/ethyl acetate=5:1~3:1~1:1)
  8. 8
    その他each recrystallized from ethyl acetate/diisopropyl ether

実験手順

A mixture of N-[6-{2-(4-bromophenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide (600 mg), (1-ethoxyvinyl)tributyltin (680 mg), bis(triphenylphosphine)palladium (II) chloride (35.5 mg) and dioxane (24 ml) is refluxed for 18 hours. The mixture is diluted with ethyl acetate, and thereto is added 10% aqueous potassium fluoride solution, and the precipitated crystals are removed by filtration. The filtrate is extracted with ethyl acetate, and the ethyl acetate layer is washed, dried, and concentrated to dryness under reduced pressure. The residue is purified by silica gel column chromatography (solvent; n-hexane/ethyl acetate=5:1~3:1~1:1), and the obtained compounds are each recrystallized from ethyl acetate/diisopropyl ether to give 4-tert-butyl-N-{5-(4-methylphenyl)-6-(2-phenoxyethoxy)pyrimidin-4-yl}benzenesulfonamide (Compound A) (42 mg), N-[6-{2-(4-acetylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide (Compound B) (242 mg) and 4-tert-butyl-N-[6-{2-(4-ethoxycarbonylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]benzenesulfonamide (Compound C) (58 mg), respectively.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US05728706uspto-grants-1998_03